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Homogenates of skin from 2- to 3-day old mice converted labeled eicosa-8.11,14-trienoic 
acid to prostaglandins (PGsl PGE, D, and F 1". For several reasons PGD~ has been 
overlooked as a possible major PG in skin. The relative formation of each PG was modified 
by the presence of reduced glutathione (GSH), chelating agents (EDTA. EGTA>. and L-
epinephrine. Chelating agents and L-epinephrine increased conversion , especially to PGE1 
but this effect was not due to inactivation of Ca- which was shown to have no control. over 
the reaction. Cyclic nucleotides including cyclic AMP (cAMP> and cyclic GMP (cGMP) were 
also ineffective . The conversion occurred mostly in the epidermis. Epidermal preparations 
were more efficient in the conversion than those from whole skin . Indomethacin (0.2 mM) 
completely inhibited t he reaction. 
Analytical gas-chromatographic studies of van 
Dorp indicated that prostaglandin (PG) E~ was the 
principal PG occurring in skin I 1.2]. This conclu-
sion was supported by a number of reports show-
ing that arachidonic acid (20:4*) was converted 
mainly to PGE~ by homogenates of young rat [3]. 
and human skin [4-6). In all of these studies re-
duced glutathione (GSH) was used . and in sev-
eral preparation!\ Pthylenediaminet.etracetic arid 
(EDTA) was included. Both of these agents in-
crease the formation of PGs. particularly E prosta-
glandins. In the absence of GSH, radioimmunoas-
say of PGs in epidermal cell extracts showed that 
F prostaglandins predominated [7]. Further. Nug-
teren and Hazelhof found that rat skin homage-
nates containing GSH but no EDTA converted 
eicosatrienoic acid (20:3*) to PGE,. PGF,". and 
PGD1 in the ratio of 1:1:2, while in subcutaneous 
connective tissue this ratio was 1:2:1 [8]. Their 
results suggest that PGD is the princ\pal class of 
skin PGs, and raise the possibility that skin com-
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Abbreviations: 
cAMP: cyclic adenosi.ne-3 ' ,5 ' -monophosphate 
cGMP: cyclic guanosine-3 ' ,5' -monophosphate 
EDTA: ethylenediaminetetracetic acid 
EGTA: ethyleneglyco-bis-(~-aminoethyl ether)-
N N '-tetracetic acid 
GSH: glutathione 
HQ: hydr oquinone 
PG: prostaglandin 
TLC: thin-layer chromatography 
* The PG precursor polyunsaturated fatty acids ar-
achidonic and eicosa-8,11.14-trienoic acids are desig-
nated as 20:4 and 20:3, respectively (number of carbon 
atoms:number of double bonds). 
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partments (epidermis. dermis) may convert prP-
cursor fatty acids to PGs in different relative 
amounts. Regional variations in the products of 
conversion ofPG intermediates have recently been 
reported for rat kidney [9]. 
Calcium is required for the activation of tissue 
phospholipase A~ which rp)eases polyunsaturated 
fatty acids (including 20:3 and 20:4) from endoge-
nom; pho!>.pholipids. The apparent increase in PG 
formation from labeled precursors in the presence 
of EDTA may be due to chelation of Ca· • and 
suppression of this release of falty acids which 
would otherwise dilute the radioactive acid [6.101. 
The effect of ca~~ can be studied more completely 
using ethy leneglycol-bis-(,13-aminoethyl etherl-N . 
N '-tetracetic acid CEGTA.l. a more specific chelator 
of ca~- 0 It is not clear whether ca~· has a direct 
effect on PG synthetase. 
Cyclic nucleotides may also exert control over 
PC synthetase. Cyclic adenosine-3' ,5' -monophos-
phate (cAMP> can increase PG levels in a variety 
of cell types [11-13[. ostensibly by activation of 
triglyceride lipase or phospholipase [14[. Direct 
addition of cAMP or its dibutyryl derivative to 
thyroid tissue bomogenates had no effect on the 
synthetase [10]. 
In the present study we reexamine the conver-
sion of precursor acids to PGs. and the effect of 
ca~... and cyclic nucleotides on homogenates of 
very young mouse skin, either whole or separated 
into dermis and epidermis. 
MATERIALS AND METHODS 
Materials . The following la beled compounds were ob-
tained from New England Nuclear Corp.: )1-1•CJeicosa-
8,11,14-trienoic acid (J «CJ20:3l with sp act 57 mCi/mM; 
I5,6-:1H)PGE1 with sp act 87 Ci/mM; I5,6-3H]PGF,n with 
sp act 85 Ci/mM. Silica gel chromatoplates were 5 x 20 
em in size, type Silplate 52 fr om Brinkmann Instru-
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ment Co. Biochemical reagents were obtained from 
Sigma. Liquid scintillation fluid used was Formula 
950A from New England Nuclear. Prostaglandins E ,, 
F ,.,, D,, A, and B, were gifts of the Upjohn Co. , Kala-
mazoo, Michigan. 
Buffer solutions. All buffers were adjusted to pH 8.0 
at 26•C. Buffer A: Tris-K2 HPO. (0.1 M); B: buffer A plus 
reduced glutathione (2 mM); C: buffer B plus EGTA (1 
mM} or EDTA (]0 mM}, or both; D: buffer B plus hydro-
quinone (HQ) (0.35 mM). 
Tissue preparation. Swiss-Webster mice (2 to 3 days 
old) were sacrificed and their skin removed. Subcuta-
neous fat was scraped off with a dull scalpel. The skins 
were poole<!. rinsed with saline, blotted dry , weighed, 
minced, and homogenized in a Dual! glass homogenizer 
in buffer A, B, or C as required using 3-4 ml per gm 
skin. The homogenate was centrifuged (900 g . 15 min. 
4•c1 and the supernatant recentrifuged (} 00,000 g , 90 
min, 4°C) to provide a pellet which was transferred to a 
glass homogenizer fitted with a Teflon pestle. and re-
suspended in buffer A or D to give a particulate prepa-
ration with protein concentration of 10-15 mg/ml. ln 
some experiments the second centrifugation was omit-
ted; in these cases the first supernatant was used and is 
referred to as "crude homogenate." 
When required, skin was separated into dermis and 
epidermis by the NH4CI method 115]. and each skin 
component was homogenized separately and treated as 
above. 
Converswn of precursors. Experimental tubes con-
tained particulate preparation or crude homogenate (1 
mil. ll-'4C leicosatrienoic acid <0.25 ~-tCil. and, when 
required. one or more of the following: calcium acetate 
(0.01-1.0 mM). indomethacin 10.2 mMJ. cAMP W. 01 and 
0.1 mMl. and cGMP (0.001 mM). Tubes were flushed 
with 0". capped and shaken at 37•c for 30 min. Ethanol 
(3 ml ). carriers PGE, and PGF,0 (]0 J-tg each!, and also 
I"HIPGE, and r~H]PGF,,. (10,000 dpm each) were added 
to each tube. 
Chromatograph;.•. Reaction mixtures were extracted 
with ether 13 x 10 mil at pH 4 and PGs isolated by t he 
method ofBauminger 116). The final pooled ether solu-
tions were diluted with about 1/ 3 of their volume of 
dichloromethane. dried with Na2SO. (anhydrous) and 
evaporated to about 50 ~-tl. before applying to silica gel 
chromatoplates as streaks. Plates were developed with 
Nugteren's solvent system '"E" f8]. Chromatoplates 
were scraped off in bands 6-mm wide into scintillation 
vials which were filled with fluid and count£>d for HC 
and 3H after standing overnight. Standard samples run 
alongside the streak were visual ized by phosphomolyb-
date spray and heat at 120°C. 
RESULTS 
Up to 5.5% of the added I'4C)20:3 was converted 
to a number of compounds. Figure 1 illustrates 
typical radioactivity patterns of these compounds 
after separation by thin-layer chromatography 
CTLC). Three were identified as PGE,. PGD,, and 
PGF 11, by the coincidence of their HC radioactivity 
peaks with authentic samples run alongside, by 
r eference to }\data in the literature 181. and by 
the coincidence of )3H)PGE 1 and f:1H1PGF,,. (added 
to monitor recovery) peaks, with the HC peaks 
attributed to PGE, and PGF,". Further evidence 
for the identity of the PGE, peak was obtained by· 
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FIG. 1. Pattern of ••c observed on chromatoplates 
after development with solvent system "E." Reaction 
mixtures contained I14C]20:3, GSH, HQ, EGTA (0.25 
mM), and protein (15 mg: particulate fraction). Bands 6 
mm wide were marked and scraped off the plates as 
indicated. 
scraping off the PGE, area, extracting with 
CHCla:CHaOH (1:1, v/v) and converting the ex-
tracted mat-erial to PGB1 )6]. Several other peaks 
were not identified. They did not correspond to 
authentic samples ofPGA, or PGB, and are proba-
bly hydroxylated fatty acids f171. Recovery of 
PGE, and PGF,a was 50 to 75%. As f3H]PGD, is 
not commercially available, recovery of PGD, was 
assumed lu equallhal uf its isomer, PGE 1• Experi-
mental mixtures which had been heated to 100°C 
for 3 min, before addition of f3H)20:3 sometimes 
showed small amounts of radioactivity (100-150 
cpml in the ru·ea occupied by PGF,a (Fig. 1). 
The labeled precursor I 14C]20:3 was selected as 
substrate because endogenous levels of 20:3 are 
low Oess than 0.10 ~g/10 mg protein of particulate 
fractions as determined by gas-liquid chromatog-
raphy) and conversion could be based on specific 
activity alone. 
Crude homogenates without additions converted 
fHC]20:3 to PGF1"" PGE,. and PGD1 in the 
amounts shown in Table I. top line. Particulate 
preparations containing added GSH and HQ 
formed mainly F ,a with smaller amounts ofE, and 
D, (Tab. I. line 2). When homogenization was 
carried out in buffer containing GSH and EGT A or 
EDTA. and Ca ... . contamination a' oided by the 
use of plastic and acid-washed glassware in subse-
quent operations. conversion of )14C]20:3 was little 
affected (Tab. I. line 3). When Cah was rigorously 
excluded by the addition of EGTA to the buffer 
used in suspending particulate preparations. con-
version to PGF," and PGE, was increased. espe-
cially to the latter, i.n dose-dependent fashion. and 
formatlon of PGD, (and other unidentified radio-
active compounds not shown in Table !) became 
relatively negl igible. The effect of EGTA resem-
bled that ofEDTA. 
The presence of Ca"'"+ did not affect the conver-
sion. In mixtures containing EGTA (0.25 mM) and 
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TABLE I. A mount of eicosa-8.1 1 .14-trienoi.c acid converted to PGs by preparations of uery young mouse skin 
No. of 
determina tions Additions PGF,. PGE, PGD, 
( ng/30 minlmg protein) 
4 None" 0.14 = 0.02 0.19 = 0.03 0.16 :t 0.03 
4 Noneh 0.46 ± 0.12 0.24 ::!: 0.03 0.10 ::!: 0.02 
12 None 0.48 ± 0.08 0.30 ± 0.06 0.07 = 0.04 
6 EGTA (0.25 mM) 0.60 ± 0.09 0.65 ± 0.14 0.08 ± 0.02 
8 EGTA (1.0 mM) 0.71 ± 0.19 0.92:!: 0.19 0.09 = 0.02 
8 EGTA (2.0 mM) 0.91 :!: 0.29 l. 71 ± 0.35 0.15 ± 0.03 
2 EDTA (10 mM) 0.86 = 0.35 2.50 = 0.28 0.14 ± 0.02 
10 Ca++ (0.01 mM) 0.52 = 0.06 0.31 ± 0.04 0.12 ::!: 0.03 
10 Ca·~ (1.0 IDM) 0.44 ::!: 0.07 0.25 = 0.06 0.11 ::!: 0.04 
10 EGTA (0.25 rnM) Ca'"+ (1.0 mM) 0.63 = 0.05 0.71 ± 0.08 0.06 ± 0.02 
12 L-Epinephr ine (0.2 mM) 0.53 ± 0.14 0.51 ::!: 0.10 0.12 ::!: 0.04 
10 L-Epinephrine (2.0 mM) 0.95 ± 0.08 1.93 ± 0.15 0.15 ± 0.03 
2 Indom ethacin 0.00 0.00 0.00 
8 cAMP (0.1 mM) 0.40 = 0.08 0.29::!: 0.05 0.12 = 0.02 
2 cAMP (0.1 mM) Ca·+ (0. 1 mM) 0.44 0.28 0.10 
4 cGMP (0.001 mM) 0.42 ± 0.04 0.24 ± 0.03 0.12 ± 0.02 
All preparations used particulate fractions obtained by centrifugation after homogenization in buffer C and 
resuspens ion of the pellet in buffer D except for the following: 
" Crude homogenate in buffer A was used to obtain these data. 
, Particulate fraction was used after homogenization in buffer Band resuspension in D. 
The compounds under ''Additions" were dissolved in buffer D and the pH readjusted to 8.0 if necessary prior to 
resuspension of protein pellets. 
TABLE ll. A mount of eicosa-8 .11 .14-trienoic acid 
converted to PGs by preparations from whole skin. 
dermis. and epidermis: mixtures contained GSH, HQ . 
and EGTA 11 mMJ 
PGF ,., PGE, PGD, 
f ng/30 min /mg p rotem) 
Whole skin 0.53 0.81 0.12 
Dermis 0.08 0.08 
Epidermis 2.36 7.85 0.31 
Epidermis and 2.13 4.93 0.25 
dermal protein 
(ng /30 min!gm skin) 
Whole skin 10.30 12.77 2.69 
Epidermis 28.29 84.86 2.93 
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FIG. 2. Distribution of radioactivity along chromato-
plates after development with system ''E." Reaction 
mixt ures contained epidermal particulate fraction with 
(e .- -•> and without (e - - e ) GSH, HQ, and EGTA 
(1 mM). 
excess Ca-+. the increase in conversion over con-
trol mixtures (no EGTA orCa++) could be ascribed 
to EGTA alone (Tab. L lines 4 and 10). Cyclic 
nucleotides cAMP and cGMP had no effect. with or 
without Ca"'' (0.01 mM). L-Epinephrine had t he 
same effects as EGT A. Indomethacin abolished 
the formation of any PG at the concentration used. 
Using particulate preparations from dermis and 
epidermis separated by NH~Cl , most of the PG 
synthetase activity remained with the epidermis 
(Tab. II) , confirming an earlier report I 18). With-
out additives. epidermal preparations converted 
I 14C]20:3 to a number of products which included 
PGF,u, PGE,. and PGD,, but in the presence of 
GSH, HQ. and EGTA, production of PGE, was 
great ly increased (Fig. 2). 
DISCUSSION 
The relative proportions of the various PGs 
formed from unsaturated precursor fa tty acids de-
pends on the experimental conditions. In the pres-
ence 14,6] or absence 13] ofEDTA. the main prod-
uct from arachidonic acid is PGE~. With GSH but 
withoutEDTA. Greaves and McDonald-Gibson re-
ported the formation of about equal amounts of 
PGE~ and PGF~ .. 15). These results indicated that 
PGE2 is the principal skin PG. This idea is sup-
ported by analytical data on PGE2 in skin; other 
PGs were not measured I 1,2,19). GSH and EDTA 
favor the formation of PGE, and investigators fre-
quently used TLC solvent systems which sepa-
rated E and F prostaglandins but not E and D 
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species. However, recently Nugteren and Hazelhof 
[8] and Kingston and Greaves 120] demonstrated 
the synthesis of PGD1 and POD~ in rat skin. 
Skin homogenates without additions form F, E, 
and D prostaglandins in comparable amounts 
(Tab. I , line 1 ). As the precursor acids 20:3 and 20:4 
occur in the ratio of about 1:10 121], the major skin 
PGs should be PGF2 .. , POE~, and PGD2• 
The inclusion of EDT A in homogenizing buffers 
should remove divalent ions such as ca+-+ and 
Sn'·+ which favor the formation of PGF~<. by form-
ing metal-GSH complexes which participate in 
reduction of endoperoxide intermediates 1221. 
Thus. EDTA should increase PGE 1 and PGD1 at 
the expense of PGF1., but this was not observed 
(Tab. I, compare lines 2 and 3). 
Kunze, Bohn, and Vogt found that ca++ in-
creased threefold the amounts of PGs in bovine 
seminial vesicle homogenates, while EDTA was 
somewhat inhibitory 123]. This result can be inter-
preted in terms of stimulation of phospholipase 
activity by ca-<-+ , with resultant increase in endog-
enous PO precursor fatty acids which might dilute 
labeled fatty acids added in experiments where the 
synthetase is studied by conversion to labeled PGs 
16,10]. The addition of EDTA or EGTA to skin 
homogenates increased conversion to PGE 1, and to 
a lesser e>..'i.ent PGF1,.. Ziboh has attributed this 
effect to the chelation of Ca ... - and inhibition of 
phospholipase [6], but in the absence of other diva-
lent ions, this cannot explain the preferential 
stimulation of POE formation over PGF. In the 
present study, rigorous exclusion of Ca ... +. or the 
presence of added Ca++ had no effect. Thus. chelat-
ing agents can increase synthetase activity by 
mechanisms which do not involve divalent ions. 
Cyclic AMP increases PO levels in a variety of 
cells by activation of triglyceride or phospholipase 
112-151. This explanation is unsatisfactory in some 
cases. For instance, cAMP stimulates the conver-
sion of labeled fatty acids to PGs in thyroid slices, 
and this is abolished by EDTA [ 10]. On the basis of 
lipase activation, the ~onversion should be dimin-
ished by cAMP and augmented by EDTA. The 
action of cAMP on PO synthetase in jntact skin is 
under investigation. 
Indomethacin abolished synthetase activity at 
the sole concentration tested (0.2 mM). This result 
does not support the finding of Greaves and Mc-
Donald-Gibson that the drug al comparable levels 
produced about. 50o/c inhibition of the conversion of 
20:4 to PGF2., but did not affect the formation of 
PGE2 124]. 
In terms of protein, the conversion of precursor 
to PGs was much higher in epidermis than in 
whole skin (Tab. II). This cannot be explained 
solely on the basis of the partial purification cf the 
synthetase which obviously results from the elimi-
nation of the dermis. In further experiments the 
total amounts of PGs formed by protein obtained 
from 1 gm of whole skin were below the corre-
sponding levels formed by epidermal protein de-
rived from the same weight of skin (Tab. II). This 
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suggested that the synthetic pathway was in-
hibited at some point by a factor present in the 
dermis and sedimented by the 100,000 g centrifu-
gation of whole-skin homogenate. However, epi-
dermal synthesis was not significantly affected by 
the addjtion of dermal protein (Tab. ll, lines 3 and 
4). Ziboh found that the addition of centrifugation 
supernatant fluid to particulate epidermal prepa-
rations inhibited the formation of POEt from 20:4 
161. The suppression of synthetase activity by 
whole-skin particulate fractions is under further 
study. 
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